These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 1281186)

  • 41. B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.
    Tan R; Teh SJ; Ledbetter JA; Linsley PS; Teh HS
    J Immunol; 1992 Nov; 149(10):3217-24. PubMed ID: 1385518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
    Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
    J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity.
    Van Gool SW; de Boer M; Ceuppens JL
    J Immunol; 1993 Apr; 150(8 Pt 1):3254-63. PubMed ID: 7682237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.
    Metz DP; Farber DL; Taylor T; Bottomly K
    J Immunol; 1998 Dec; 161(11):5855-61. PubMed ID: 9834064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD28 functions as an adhesion molecule and is involved in the regulation of human IgE synthesis.
    Life P; Aubry JP; Estoppey S; Schnuriger V; Bonnefoy JY
    Eur J Immunol; 1995 Feb; 25(2):333-9. PubMed ID: 7533083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of CTLA-4 expression during T cell activation.
    Perkins D; Wang Z; Donovan C; He H; Mark D; Guan G; Wang Y; Walunas T; Bluestone J; Listman J; Finn PW
    J Immunol; 1996 Jun; 156(11):4154-9. PubMed ID: 8666782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes.
    Fabry Z; Sandor M; Gajewski TF; Herlein JA; Waldschmidt MM; Lynch RG; Hart MN
    J Immunol; 1993 Jul; 151(1):38-47. PubMed ID: 8100844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor.
    Freeman GJ; Cardoso AA; Boussiotis VA; Anumanthan A; Groves RW; Kupper TS; Clark EA; Nadler LM
    J Immunol; 1998 Sep; 161(6):2708-15. PubMed ID: 9743327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
    Croft M; Swain SL
    J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.
    Greenfield EA; Howard E; Paradis T; Nguyen K; Benazzo F; McLean P; Höllsberg P; Davis G; Hafler DA; Sharpe AH; Freeman GJ; Kuchroo VK
    J Immunol; 1997 Mar; 158(5):2025-34. PubMed ID: 9036945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen.
    Burr JS; Kimzey SL; Randolph DR; Green JM
    Am J Respir Cell Mol Biol; 2001 May; 24(5):563-8. PubMed ID: 11350825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response.
    Lucas PJ; Negishi I; Nakayama K; Fields LE; Loh DY
    J Immunol; 1995 Jun; 154(11):5757-68. PubMed ID: 7751626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B70 antigen is a second ligand for CTLA-4 and CD28.
    Azuma M; Ito D; Yagita H; Okumura K; Phillips JH; Lanier LL; Somoza C
    Nature; 1993 Nov; 366(6450):76-9. PubMed ID: 7694153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The B7-CD28 superfamily.
    Sharpe AH; Freeman GJ
    Nat Rev Immunol; 2002 Feb; 2(2):116-26. PubMed ID: 11910893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
    Champagne E; Scarpellino L; Lane P; Acha-Orbea H
    Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
    Sperling AI; Auger JA; Ehst BD; Rulifson IC; Thompson CB; Bluestone JA
    J Immunol; 1996 Nov; 157(9):3909-17. PubMed ID: 8892622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo.
    Vella AT; Mitchell T; Groth B; Linsley PS; Green JM; Thompson CB; Kappler JW; Marrack P
    J Immunol; 1997 May; 158(10):4714-20. PubMed ID: 9144484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.